Building leading companies.
Companies which offer B2B products and services, based on innovation, advanced engineering or software.
May 21, 2015Successful investment pathways leading to excellent annual result of EUR 136.0 million - Net asset value up 14% to EUR 42.97 per share - Stable gross dividend of EUR 2.45, representing a dividend yield of 5.8%
May 15, 2015Gimv portfolio company Prosonix to be acquired by Circassia Pharmaceuticals
May 7, 2015Gimv and the other shareholders are selling their stake in Acertys Groep, a major supplier to hospitals and medical professions